AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Nancy McVicar
FORT LAUDERDALE, Fla. _ A drug commonly used to treat enlarged prostates and baldness also cuts the risk of prostate cancer by about 25 percent, researchers said Tuesday. But experts stopped short of recommending that every man at risk for the disease begin taking it.
Prostate cancer is the most common non-skin cancer in the United States with more than 220,000 new cases diagnosed each year, and many more going undetected. It kills about 29,000 each year, second only to lung cancer.
The drug finasteride, approved in 1992 and sold as Proscar to treat enlarged prostates and Propecia to treat baldness, was studied in a seven-year…
Source: HighBeam Research, Research shows drug may cut prostate cancer risk.